Draw
Home Products

AG00HXEE

145202-66-0 | Rizatriptan Benzoate

145202-66-0
AG00HXEE
sdsSDS
sdsCOA
TIP This product is typically in stock.Please contact us for quotation.
Request For Quotation

CAS Number 145202-66-0
Catalog Number AG00HXEE(AGN-PC-07Y4VM)
Chemical Name Rizatriptan Benzoate
IUPAC Name benzoic acid;N,N-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethanamine
InChI InChI=1S/C15H19N5.C7H6O2/c1-19(2)6-5-13-8-17-15-4-3-12(7-14(13)15)9-20-11-16-10-18-20;8-7(9)6-4-2-1-3-5-6/h3-4,7-8,10-11,17H,5-6,9H2,1-2H3;1-5H,(H,8,9)
InChI Key JPRXYLQNJJVCMZ-UHFFFAOYSA-N
MDL Number MFCD00866224
Molecular Formula C22H25N5O2
Molecular Weight 391.4662
NSC Number 758919
SMILES CN(C)CCC1=CNC2=C1C=C(CN3N=CN=C3)C=C2.O=C(O)C4=CC=CC=C4
UNII WR978S7QHH
Synonyms
L 705,126, L 705126, L-705,126, L-705126, Maxalt, MK 0462, MK 462, MK-0462, MK-462, N,N-dimethyl-2-(5-(1,2,4-triazol-1-ylmethyl)-1H-indole-3-yl)ethylamine, rizatriptan, rizatriptan benzoate, Rizatriptan benzoate, 145202-66-0, Maxalt, Maxalt-MLT, MK-462, MK 462, Rizatriptan (benzoate), MK-0462, UNII-WR978S7QHH, MK 0462, Rizatriptan benzoate [USAN:USP], 2-(5-((1H-1,2,4-TRIAZOL-1-YL)METHYL)-1H-INDOL-3-YL)-N,N-DIMETHYLETHANAMINE BENZOATE, L 705126, L-705126, WR978S7QHH, L 705,126, L-705,126, N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethylamine benzoate, Rizatriptan Benzoate (Maxalt), AK163196, 1H-Indole-3-ethanamine, N,N-dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-, monobenzoate, 3-(2-(Dimethylamino)ethyl)-5-(1H-1,2,4-triazol-1-ylmethyl)indole monobenzoate, benzoic acid; N,N-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethanamine, Rizatriptan Benzoate [USAN], benzoic acid;N,N-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethanamine, Rizatriptan(RIZ), C15H19N5.C7H6O2, rizatrimptan benzoate, rizatriptane benzoate, rizatriptan, benzoate, MK-462 Benzoate, benzoic acid; rizatriptan, MK-462;Maxalt;Maxalt, AC1L2U9K, Rizatriptan-Benzoate(Maxalt), SCHEMBL41226, MLS001424197, Rizatriptan Benzoate(Maxalt)/, CHEBI:8875, CHEMBL1201032, KS-00000XKR, DTXSID20162937, RHB-103, JPRXYLQNJJVCMZ-UHFFFAOYSA-N, Rizatriptan benzoate (JAN/USAN), HMS2051B16, HMS2093K08, HMS2235M18, HMS3369I15, HMS3393B16, HMS3655K09, HMS3715D08, Pharmakon1600-01505189, ACT04340, BCP02149, HY-B0206, INT-0008, ABP000203, AC-734, BG0594, MFCD00866224, NSC758919, AKOS015855933, N,N-dimethyl-2-(5-(1,2,4-triazol-1-ylmethyl)-1H-indole-3-yl)ethylamine, AB07521, API0004087, CCG-101039, CS-2147, KS-1189, NC00289, NSC-758919, RL01822, AN-15582, BC208268, CPD000525252, SAM001246615, SMR000525252, AB0011227, AB2000157, AX8006648, LS-173238, Rizatriptan benzoate salt, >=98% (HPLC), FT-0631171, R0107, R0181, S1607, ST24039483, SW197669-2, D00675, X-2040, 202R660, SR-01000763588, I01-0305, J-008071, J-524222, SR-01000763588-3, Rizatriptan benzoate, European Pharmacopoeia (EP) Reference Standard, Rizatriptan benzoate, United States Pharmacopeia (USP) Reference Standard, 1H-Indole-3-ehtanamine,N,N-dimehtyl-5-(1H-1,2,4-triazol-1-ylmethyl)-,monobenzoate, 2-(5-((1H-1,2,4-triazol-1-yl)methyl)-1H-indol-3-yl)-N,N-dimethylethan-1-amine benzoate, DIMETHYL-[2-(5-[1,2,4]TRIAZOL-1-YLMETHYL-1H-INDOL-3-YL)-ETHYL]-AMINE BENZOATE, N,N-DIMETHYL-5-(1H-1,2,4-TRIAZOL-1-YLMETHYL)-1H-INDOLE-3-ETHANAMINE BENZOATE, Rizatriptan for system suitability, European Pharmacopoeia (EP) Reference Standard, benzoic acid2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]-N,N-bis(trideuteriomethyl)ethanamine, rizatriptan, Rizatriptanbenzoate, Rizatriptan Bezoate, Maxalt (TN), RIZATRIPTAN MONOBENZOATE, C22H25N5O2, CID77997, Rizatriptan benzoate, 99% - 1G 1g, ACN-048281, CS-O-02233, C15-H19-N5.C7-H6-O2, A8516, C093622, N,N-dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine,benzoate (1:1),

Product Recommendations

    CERTIFICATE OF ANALYSIS
    Chemical Name: Batch Number:
    Chemical Structure: CAS Registry No:
    		Product ID:
    Manufacture Date:
    Storage Temperature:
    Formula:
    Molecular Weight:
    Quantity:
    Analysis Data:
    Test: Result:
    Conclusion: The above product meets the specifications of Angene.
    Analyst:Chase
    Date:
    Reviewed by:Jessie
    Date:
    Angene International Limited